Dorsey & Whitney Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Buy |
20,359
+1,754
| +9% | +$140K | 0.07% | 238 |
|
|
2025
Q4 | $1.77M | Buy |
18,605
+2,730
| +17% | +$268K | 0.09% | 178 |
|
|
2025
Q3 | $1.55M | Buy |
15,875
+249
| +2% | +$25.8K | 0.08% | 196 |
|
|
2025
Q2 | $1.68M | Buy |
15,626
+922
| +6% | +$93.3K | 0.09% | 190 |
|
|
2025
Q1 | $1.48M | Buy |
14,704
+490
| +3% | +$49.3K | 0.09% | 204 |
|
|
2024
Q4 | $1.27M | Buy |
14,214
+257
| +2% | +$22.6K | 0.07% | 218 |
|
|
2024
Q3 | $1.17M | Buy |
13,957
+1,561
| +13% | +$123K | 0.06% | 233 |
|
|
2024
Q2 | $955K | Sell |
12,396
-620
| -5% | -$45.4K | 0.07% | 231 |
|
|
2024
Q1 | $891K | Buy |
13,016
+1,732
| +15% | +$111K | 0.06% | 235 |
|
|
2023
Q4 | $652K | Sell |
11,284
-2,095
| -16% | -$112K | 0.05% | 280 |
|
|
2023
Q3 | $706K | Buy |
13,379
+1,748
| +15% | +$91.7K | 0.06% | 245 |
|
|
2023
Q2 | $629K | Buy |
11,631
+2,342
| +25% | +$122K | 0.05% | 278 |
|
|
2023
Q1 | $465K | Sell |
9,289
-184
| -2% | -$8.67K | 0.04% | 320 |
|
|
2022
Q4 | $433K | Buy |
9,473
+291
| +3% | +$12.6K | 0.04% | 328 |
|
|
2022
Q3 | $355K | Buy |
9,182
+14
| +0.2% | +$562 | 0.04% | 357 |
|
|
2022
Q2 | $344K | Buy |
9,168
+229
| +3% | +$9.32K | 0.03% | 366 |
|
|
2022
Q1 | $396K | Buy |
8,939
+3,256
| +57% | +$141K | 0.03% | 346 |
|
|
2021
Q4 | $242K | Sell |
5,683
-2,483
| -30% | -$104K | 0.02% | 476 |
|
|
2021
Q3 | $353K | Hold |
8,166
| – | – | 0.03% | 363 |
|
|
2021
Q2 | $349K | Sell |
8,166
-1,352
| -14% | -$56.9K | 0.03% | 359 |
|
|
2021
Q1 | $368K | Hold |
9,518
| – | – | 0.04% | 342 |
|
|
2020
Q4 | $343K | Buy |
9,518
+63
| +0.7% | +$2.27K | 0.04% | 313 |
|
|
2020
Q3 | $361K | Sell |
9,455
-470
| -5% | -$18.1K | 0.05% | 264 |
|
|
2020
Q2 | $348K | Buy |
9,925
+893
| +10% | +$32.2K | 0.05% | 277 |
|
|
2020
Q1 | $294K | Buy |
9,032
+250
| +3% | +$9.77K | 0.05% | 279 |
|
|
2019
Q4 | $397K | Buy |
8,782
+269
| +3% | +$11.3K | 0.05% | 271 |
|
|
2019
Q3 | $346K | Buy |
8,513
+1,164
| +16% | +$49.3K | 0.05% | 278 |
|
|
2019
Q2 | $316K | Buy |
7,349
+38
| +0.5% | +$1.46K | 0.05% | 278 |
|
|
2019
Q1 | $281K | Sell |
7,311
-376
| -5% | -$14.4K | 0.04% | 293 |
|
|
2018
Q4 | $271K | Buy |
7,687
+265
| +4% | +$9.61K | 0.05% | 277 |
|
|
2018
Q3 | $286K | Sell |
7,422
-1,278
| -15% | -$44.6K | 0.04% | 295 |
|
|
2018
Q2 | $284K | Buy |
8,700
+355
| +4% | +$10.7K | 0.05% | 269 |
|
|
2018
Q1 | $228K | Hold |
8,345
| – | – | 0.04% | 312 |
|
|
2017
Q4 | $207K | Buy |
+8,345
| New | +$230K | 0.04% | 320 |
|
|
2017
Q3 | – | Sell |
-8,318
| Closed | -$231K | – | 349 |
|
|
2017
Q2 | $231K | Hold |
8,318
| – | – | 0.05% | 277 |
|
|
2017
Q1 | $207K | Buy |
+8,318
| New | +$202K | 0.04% | 299 |
|
Other funds holding BSX
VCM
VPM
Dorsey & Whitney Trust's BSX Position: Q1 2026 in Review
Dorsey & Whitney Trust increased its Boston Scientific (BSX) stake by 9.4% in Q1 2026, buying an estimated $140K and bringing the position to 20,359 shares worth $1.28M. The position accounts for 0.07% of the portfolio, ranked #238.
Dorsey & Whitney Trust first reported a position in BSX in Q1 2017 and has held it in 36 quarters since. The position peaked at $1.77M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Dorsey & Whitney Trust held 20,359 shares of Boston Scientific worth $1.28M as of Q1 2026.
- Dorsey & Whitney Trust bought 1,754 Boston Scientific shares in Q1 2026, an estimated $140K.
- Boston Scientific made up 0.07% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #238 holding.
- Dorsey & Whitney Trust first reported a position in Boston Scientific in Q1 2017 and has held it in 36 quarters since.
- Dorsey & Whitney Trust's Boston Scientific position peaked at $1.77M in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.